Contracts › 75N91018F00003
75N91018F00003: Award of Task Order 3 Entitled "A Dual Akt/PDPK1 Inhibitor for Actinic Keratosis and Skin Cancer Prevention in Immunocompromised Individuals"
Awarded to University of Illinois by National Institutes of Health (NIH).
$2.3Mobligated
$2.3Mpotential value
30 July 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N91018F00003 |
|---|---|
| Vehicle | HHSN261201500026I |
| Awardee | University of Illinois |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NIH NCI |
| NAICS | 541711 Research and Development in Biotechnology |
| PSC | AN11 Health R&D Services; Health Care Services; Basic Research |
| Place of performance | IL |
| Offers received | 2 |
| Period of performance | 17 September 2018 to 30 July 2026 |
| Potential end | 30 July 2026 |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541711 contracts · All expiring contracts · USASpending record